Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Sitryx Therapeutics describes new NFE2L2 activators

May 25, 2022

Shanghai Blueray Biopharma discloses PTPN11 mutant inhibitors

May 25, 2022

Adorx Therapeutics patents new CD73 inhibitors

May 25, 2022

PharmaCyte studies pancreatic cancer therapy to treat malignant ascites

May 24, 2022

New c-Myc inhibitors presented by Suzhou Kintor Pharmaceuticals

May 24, 2022

Boehringer Ingelheim Pharma KG identifies new EGFR mutant inhibitors

May 24, 2022

Loss of PHGDH potentiates metastatic dissemination

May 24, 2022

New PROTACs developed by Luzhou Baicaotang Chinese Traditional Medicine

May 23, 2022

Shanghai Meizer Pharmaceuticals presents new PTPN11 inhibitors

May 23, 2022

Immix reports promising survival data with IMX-110 in mouse soft tissue sarcoma study

May 23, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...